[HLBANK] YoY Annual (Unaudited) Result on 30-Jun-2017 [#4]

Announcement Date
24-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2017
Quarter
30-Jun-2017 [#4]
Profit Trend
YoY- 12.69%
View:
Show?
Annual (Unaudited) Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 4,778,356 4,725,835 4,839,565 4,550,649 4,177,862 4,066,948 4,039,059 2.83%
PBT 2,989,397 3,186,020 3,246,255 2,748,252 2,381,699 2,746,158 2,613,221 2.26%
Tax -494,800 -521,513 -608,177 -603,236 -478,282 -512,971 -510,951 -0.53%
NP 2,494,597 2,664,507 2,638,078 2,145,016 1,903,417 2,233,187 2,102,270 2.89%
-
NP to SH 2,494,597 2,664,507 2,638,078 2,145,016 1,903,417 2,233,187 2,102,270 2.89%
-
Tax Rate 16.55% 16.37% 18.73% 21.95% 20.08% 18.68% 19.55% -
Total Cost 2,283,759 2,061,328 2,201,487 2,405,633 2,274,445 1,833,761 1,936,789 2.78%
-
Net Worth 27,221,136 25,472,637 23,893,507 22,684,628 19,683,995 16,801,905 14,511,773 11.04%
Dividend
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div 736,812 1,022,997 981,924 920,476 782,019 724,372 722,066 0.33%
Div Payout % 29.54% 38.39% 37.22% 42.91% 41.09% 32.44% 34.35% -
Equity
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 27,221,136 25,472,637 23,893,507 22,684,628 19,683,995 16,801,905 14,511,773 11.04%
NOSH 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 1,766,761 1,761,137 3.51%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 52.21% 56.38% 54.51% 47.14% 45.56% 54.91% 52.05% -
ROE 9.16% 10.46% 11.04% 9.46% 9.67% 13.29% 14.49% -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 233.47 230.98 236.58 222.47 219.04 230.19 229.34 0.29%
EPS 121.88 130.23 128.96 104.86 99.79 126.40 119.37 0.34%
DPS 36.00 50.00 48.00 45.00 41.00 41.00 41.00 -2.14%
NAPS 13.30 12.45 11.68 11.09 10.32 9.51 8.24 8.29%
Adjusted Per Share Value based on latest NOSH - 2,167,718
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 220.43 218.01 223.26 209.93 192.73 187.61 186.33 2.83%
EPS 115.08 122.92 121.70 98.95 87.81 103.02 96.98 2.89%
DPS 33.99 47.19 45.30 42.46 36.08 33.42 33.31 0.33%
NAPS 12.5575 11.7509 11.0224 10.4647 9.0805 7.751 6.6945 11.04%
Price Multiplier on Financial Quarter End Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 14.08 19.00 18.20 15.66 13.18 13.40 13.80 -
P/RPS 6.03 8.23 7.69 7.04 6.02 5.82 6.02 0.02%
P/EPS 11.55 14.59 14.11 14.93 13.21 10.60 11.56 -0.01%
EY 8.66 6.85 7.09 6.70 7.57 9.43 8.65 0.01%
DY 2.56 2.63 2.64 2.87 3.11 3.06 2.97 -2.44%
P/NAPS 1.06 1.53 1.56 1.41 1.28 1.41 1.67 -7.28%
Price Multiplier on Announcement Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 28/08/20 28/08/19 28/08/18 24/08/17 29/08/16 26/08/15 26/08/14 -
Price 14.00 16.26 20.00 15.50 13.12 12.92 14.00 -
P/RPS 6.00 7.04 8.45 6.97 5.99 5.61 6.10 -0.27%
P/EPS 11.49 12.49 15.51 14.78 13.15 10.22 11.73 -0.34%
EY 8.71 8.01 6.45 6.77 7.61 9.78 8.53 0.34%
DY 2.57 3.08 2.40 2.90 3.13 3.17 2.93 -2.15%
P/NAPS 1.05 1.31 1.71 1.40 1.27 1.36 1.70 -7.70%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment